VivoSeq
Dermatology

Burns

0

Pipeline Programs↗

7

Active Trials↗

3

Companies Involved↗

Burns is an early-stage landscape with 0 programs across 3 companies. The most active players are Noveome Biotherapeutics, formerly Stemnion, Pfizer, SpectralMD.

Intelligence

Pipeline Metrics

Competitive Density

22/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

62/100

Attrition Rate

25/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

N

Noveome Biotherapeutics, formerly Stemnion

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalS

SpectralMD

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

20

clinical trials

Completed8 · 40%
Terminated4 · 20%
Recruiting3 · 15%
Enrolling by invitation3 · 15%
Withdrawn1 · 5%
Not yet recruiting1 · 5%

Clinical Trials

Trial Activity

20 trials

4-Aminopyridine to Treat Skin Burns
Recruiting·—·Phase 2·NCT06596434·200 enrolled
Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns
Recruiting·VVanderbilt University Medical Center·Phase 1·NCT05856994·18 enrolled
Pilot Study on the Design of a 3D-printed Differential Pressure Distribution Orthosis for the Treatment of Post-burn Hypertrophic Scarring
Recruiting·CCentre Hospitalier Régional Metz-Thionville·Preclinical·NCT06487910·25 enrolled
Deepview HHF Training and Validation Label Expansion Study
Not yet recruiting·SSpectralMD·N/A·NCT07677657·280 enrolled
Comparison of Amniotic Membrane Dressing and Aquacel®Ag in Second-degree Burns
Enrolling by invitation·PPatel Hospital, Pakistan·N/A·NCT07300137·100 enrolled
SN514-066b Enzyme in Deep Partial Thickness Burns
Enrolling by invitation·SSERDA bv·Phase 1/2·NCT06628037·27 enrolled
The Effects of Non-Invasive Vagus Nerve Stimulation on Inflammatory Response and Functional Recovery in Patients With Acute Burn Injuries
Enrolling by invitation·FFenerbahce University·Preclinical·NCT07574580·50 enrolled
The Effect of Two Versus Ten Days Application of Flammacerium in Partial Thickness Burns
Completed·AAssociation of Dutch Burn Centres·Phase 4·NCT00156988
Evaluation Of Linezolid Pk Profile In Burns Patients
Completed·Pfizer logoPfizer·Phase 1·NCT00255996·16 enrolled
Comparison of a Water-soluble Topical Antimicrobial to Silver Sulfadiazine in Partial Thickness Burns
Completed·UUniversity of Virginia·Phase 4·NCT01926392·8 enrolled
Feasibility Study: Enzymatic Debridement in Patients With Partial Thickness Burns
Completed·MMediWound Ltd·Phase 2·NCT00898521·36 enrolled
Pharmacokinetics Ertapenem Burns
Completed·NNantes University Hospital·Phase 4·NCT01497990·8 enrolled
Enzymatic Debridement in Burns Patients: A Comparison to Standard of Care
Completed·MMediWound Ltd·Phase 3·NCT00324311·182 enrolled
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
Completed·SStratatech, a Mallinckrodt Company·Phase 1·NCT01437852·30 enrolled
Efficacy of Whole-Body Vibration Training on Thermal Burn Injury in Paediatrics: A Prospective Randomized Controlled Trial
Completed·CCairo University·Preclinical·NCT06116227·60 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)